MetP Pharma Receives US Patent For Drug Therapy Of Demyelinating And Neuroinflammatory Diseases Such As Multiple Sclerosis Read more
Exclusive Interview From Christiane Niederlaender, Director At AMBR Consulting Ltd, Released Ahead Of SMi’s RNA Therapeutics Conference Read more